Cramer looks at the number of company's selling burgers and tries to determine the quality names, as well as those to avoid.» Read More
Wall Street’s been soaking in red, but Jim Cramer has one signal to watch for that could point to another run in the "Mad Money" review.
Jim Cramer sees that between Shake Shack and Red Robin there are too many chefs in the kitchen. Should you join the burger war?
Jim Cramer highlights that the U.S. is spending less on our military, but does that mean defense stocks are a lost cause? Maybe not.
Jim Cramer reveals his game plan of stocks and market events he is watching next week. Could the Humana rumors turn into a big deal on Monday?
In Mad Money's Executive Cut, CEOs cover everything from organic food to train safety with host Jim Cramer.
CNBC's Melissa Lee and the Options Action traders discuss the stocks they'll be watching next week.
A willing oil trade. Why aren't oil stocks rallying? And a bullish trade on Google. With CNBC's Melissa Lee and the Options Action traders.
Deal chatter heats up, as autos look to shift into high gear, with CNBC's Melissa Lee and the Options Action traders.
Biotech stocks near their record highs. Is there a biotech breakout ahead? And is it too late to buy in? With CNBC's Melissa Lee and the Options Action traders.
Industrials have lagged the market. Should investors play for a pullback? With CNBC's Melissa Lee and the Options Action traders.
The Fast Money traders share their final trades of the day.
The "Fast Money" traders give you 5 plays in the biotech sector.
CNBC's Melissa Lee and the Fast Money traders look at what some may consider the world's best catch-up trade.
The Fast Money traders take a look at today's biggest market movers.
Dissecting the day's major business news, with the Fast Money traders. Bristol-Myers gets hit hard on disappointing results from a lung cancer drug.
Jeff Vink, Tampa Bay Lighting owner, discusses if stock pickers are needed to find growth in this market. Also, the building up city of Tampa.
David Darst, independent investment consultant, discusses what investors should focus on. Keep your eye on the bank stocks, says Darst.
CNBC Pro highlights the top performing stocks this week and analyzes whether the good times will continue.
Legendary trader Laszlo Birinyi sees all the bearish talk from his peers and the media and takes the opposite view.
Lilly never stops innovating, says CNBC's Jim Cramer explaining why he is watching shares of the pharmaceutical giant.